(132 days)
Not Found
No
The summary describes a standard PACS software for mobile devices and does not mention AI, ML, or related concepts in the device description, intended use, or performance studies.
No
The device is described as a diagnostic, review, and analysis tool used for displaying medical images, not for treating or preventing disease.
Yes
The "Intended Use / Indications for Use" section explicitly states, "The device is intended for use as a diagnostic, review, and analysis tool by trained professionals such as radiologists, physicians and technologists." Additionally, the "Summary of Performance Studies" mentions "acceptable image quality for diagnostic radiology" and clinical testing where radiologists made "Comparative assessments of image quality and diagnostic confidence."
Yes
The device is explicitly described as "software-based" and is used with "general purpose computing servers and specific mobile devices." While it relies on existing hardware (servers and mobile devices), the device itself is the software component that provides the PACS functionality. The performance studies focus on the combination of the software with off-the-shelf mobile devices, not on the development or verification of new hardware.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that ResolutionMD Mobile is a software-based Picture Archiving and Communication System (PACS) used for the communication, storage, reformatting, rendering, and display of medical images (DICOM 3.0 compliant). It is intended for use as a diagnostic, review, and analysis tool for medical professionals.
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: ResolutionMD Mobile deals with the display and manipulation of medical images acquired from imaging modalities like X-ray, ultrasound, PET, and SPECT. It does not perform any tests on biological samples.
Therefore, ResolutionMD Mobile falls under the category of medical imaging software and is not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
ResolutionMD™ Mobile is a software-based Picture Archiving and Communication System (PACS) used with general purpose computing servers and specific mobile devices. It provides for communication, storage, reformatting, rendering on the server component and communication and display of DICOM 3.0-compliant medical images as well as reports on the mobile device.
ResolutionMD Mobile provides wireless and portable access to medical images. The device is intended for use as a diagnostic, review, and analysis tool by trained professionals such as radiologists, physicians and technologists. This device is not intended to replace full workstations and should be used only when there is no access to a workstation.
ResolutionMD Mobile is not to be used for mammography.
Product codes
LLZ
Device Description
The ResolutionMD™ Mobile software is a software-based Picture Archiving and Communication System (PACS) used with general purpose computing servers and highresolution Apple Inc. iOS and Google Inc. Android OS-based wireless mobile devices for the display and advanced visualization of medical image data. It provides for communication, storage, processing, rendering on the server and the display of DICOM 3.0 compliant image data on the mobile device.
Based on benchmark testing by radiologists comparing diagnostic confidence on the X-ray, ultrasound, PET and SPECT modalities on mobile devices with ResolutionMD Mobile to a predicate PACS workstation, this version amends the Indications for Use to include all DICOM 3.0 images.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
X-ray, ultrasound, PET and SPECT, all DICOM 3.0 images
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
trained professionals such as radiologists, physicians and technologists. This device is not intended to replace full workstations and should be used only when there is no access to a workstation.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Clinical Testing: Clinical testing was conducted by a panel of nine board-certified radiologists in the United States. The radiologists conducted a side-by-side comparative assessment of the iOS and Android mobile devices running ResolutionMD Mobile with the predicate PACS workstation. A series of typical yet challenging X-ray, ultrasound, PET and SPECT cases were reviewed on each device. Comparative assessments of image quality and diagnostic confidence were made by each radiologist.
Performance Testing: Performance testing was conducted to qualify iOS and Android mobile devices, both smartphones and tablets, as devices whose off-the-shelf performance in combination with the overall attributes of the ResolutionMD Mobile solution provides acceptable image quality for diagnostic radiology. The tests were performed in accordance with the description and requirements described in the AAPM Assessment of Display Performance for Medical Imaging Devices (2005) document by an ISO 17025-certified third party to ensure high quality laboratory results. The test equipment and calibration was certified traceable to NIST. The specific results regarding the measured luminance from the mobile devices with respect to the target luminance response using JND plots was provided to the FDA as requested.
Key Results: All nine radiologists agreed that the iOS and Android mobile devices, both smartphones and tablets, were either "equivalent" or "comparable" to the predicate PACS workstation across all four modalities and of adequate quality for clinical use. They were comfortable with the diagnoses made on the mobile devices using the ResolutionMD Mobile software. All agreed that the overall clinical image display quality on the iOS and Android devices was equivalent to the PACS workstation for the identification of clinically-relevant pathology. All nine radiologists indicated that the software and devices provide acceptable quality for regular use and they were comfortable reviewing images on the devices. For all the individual cases, there was agreement by all reviewers that the same diagnosis would be made on the mobile devices with ResolutionMD as on the predicate PACS workstation in office lighting conditions and in the low light conditions. None of the reviewers noted any differences in their perception of the images between the low light and office lighting conditions.
Key Metrics
Not Found
Predicate Device(s)
K123186, K111346, K112930, K110875
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
MAR 26 2014
K133508
Page 1 of 4
5 510(k) Summary
As required by 21 CFR Part 807.87(h)
| Submitter: | Kyle Peterson
Director, Regulatory & Corporate Affairs
Calgary Scientific Inc.
Suite 208, 1210 - 20th Ave. SE
Calgary, Alberta
T2G 1M8
CANADA | |
|---------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------|
| Telephone Number: | (403) 767-7945 | |
| Fax Number: | (403) 270-2771 | |
| Name / Address of
Manufacturer: | Calgary Scientific Inc.
Suite 208, 1210 - 20th Ave. SE
Calgary, Alberta
T2G 1M8
CANADA | |
| Date of Submission: | November 12, 2013 | |
| Identification of the Device | | |
| Device Proprietary Name: | ResolutionMD Mobile | |
| Common Name: | Picture Archiving and Communication System | |
| Classification Name: | Picture Archiving and Communication System per
21 CFR 892.2050 | |
| Product Code: | LLZ | |
| Device Class: | Class II | |
| Marketed Device to which Equivalence is claimed: | | |
| Device | Manufacturer | 510(k) Number |
| ResolutionMD Mobile 3.1
ResolutionMD Mobile
Mobile MIM
Centricity PACS | Calgary Scientific Inc.
Calgary Scientific Inc.
MIM Software Inc.
GE Healthcare | K123186
K111346
K112930
K110875 |
1
Device Description:
The ResolutionMD™ Mobile software is a software-based Picture Archiving and Communication System (PACS) used with general purpose computing servers and highresolution Apple Inc. iOS and Google Inc. Android OS-based wireless mobile devices for the display and advanced visualization of medical image data. It provides for communication, storage, processing, rendering on the server and the display of DICOM 3.0 compliant image data on the mobile device.
Based on benchmark testing by radiologists comparing diagnostic confidence on the X-ray, ultrasound, PET and SPECT modalities on mobile devices with ResolutionMD Mobile to a predicate PACS workstation, this version amends the Indications for Use to include all DICOM 3.0 images.
Indications for Use:
ResolutionMD™ Mobile is a software-based Picture Archiving and Communication System (PACS) used with general purpose computing servers and specific mobile devices. It provides for communication, storage, reformatting, rendering on the server component and communication and display of DICOM 3.0-compliant medical images as well as reports on the mobile device.
ResolutionMD Mobile provides wireless and portable access to medical images. The device is intended for use as a diagnostic, review, and analysis tool by trained professionals such as radiologists, physicians and technologists. This device is not intended to replace full workstations and should be used only when there is no access to a workstation.
ResolutionMD Mobile is not to be used for mammography.
Technological Characteristics
The ResolutionMD™ Mobile software has the same technological characteristics as the predicate ResolutionMD Devices and has the same uses and applications as the predicate devices. Both the device and predicates are used by the clinician as a diagnostic, review, and analysis tool for radiological images.
Software Verification and Validation Testing
Verification testing consisting of more 160 separate tests, each executed multiple times by different testers, was performed for this device. Testing included functional, smoke and regression tests and was complemented by beta tests performed by Calgary Scientific's OEM distribution partners. The vast majority of tests passed our testing criteria. Any defects found or reported were either fixed or logged in the Unresolved Anomalies report included with this submission and annotated as to any impact on safety or effectiveness including applicable workarounds.
2
Validation testing based on typical clinical workflows was performed by trained radiology personnel. Validation includes usability assessment and consistency across three client platforms; Web, iOS and Android.
Performance Testing
Performance testing was conducted to qualify iOS and Android mobile devices, both smartphones and tablets, as devices whose off-the-shelf performance in combination with the overall attributes of the ResolutionMD Mobile solution provides acceptable image quality for diagnostic radiology.
The tests were performed in accordance with the description and requirements described in the AAPM Assessment of Display Performance for Medical Imaging Devices (2005) document by an ISO 17025-certified third party to ensure high quality laboratory results. The test equipment and calibration was certified traceable to NIST.
The specific results regarding the measured luminance from the mobile devices with respect to the target luminance response using JND plots was provided to the FDA as requested.
Clinical Testing
Clinical testing was conducted by a panel of nine board-certified radiologists in the United States. The radiologists conducted a side-by-side comparative assessment of the iOS and Android mobile devices running ResolutionMD Mobile with the predicate PACS workstation. A series of typical yet challenging X-ray, ultrasound, PET and SPECT cases were reviewed on each device. Comparative assessments of image quality and diagnostic confidence were made by each radiologist.
All nine radiologists agreed that the iOS and Android mobile devices, both smartphones and tablets, were either "equivalent" or "comparable" to the predicate PACS workstation across all four modalities and of adequate quality for clinical use. They were comfortable with the diagnoses made on the mobile devices using the ResolutionMD Mobile software. All agreed that the overall clinical image display quality on the iOS and Android devices was equivalent to the PACS workstation for the identification of clinically-relevant pathology.
All nine radiologists indicated that the software and devices provide acceptable quality for regular use and they were comfortable reviewing images on the devices.
For all the individual cases, there was agreement by all reviewers that the same diagnosis would be made on the mobile devices with ResolutionMD as on the predicate PACS workstation in office lighting conditions and in the low light conditions. None of the reviewers noted any differences in their perception of the images between the low light and office lighting conditions.
3
K133508
Page 4 of 4
Safety and Effectiveness
The device is designed and manufactured under Quality System Regulations as outlined in 21 CFR 820. All requirements of Picture Archiving and Communications System (21 CFR 892.2050) are met, and software is in compliance with ISO 14971 and ISO 62304.
Substantial Equivalence:
Based on the above considerations, Calgary Scientific Inc. believes that the ResolutionMD Mobile software is substantially equivalent to the predicate devices. The device and the predicates are post-processing and provide the same or similar essential features of visualization of radiological data on mobile devices.
4
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized depiction of an eagle or bird-like figure with three curved lines representing its wings or body. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged around the emblem in a circular fashion.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
March 26, 2014
Calgary Scientific, Inc. % Mr. Kyle Peterson Director, Regulatory & Corporate Affairs Suite 208, 1210 -20th Avenue SE Calgary, Alberta T2G 1 M8 CANADA
Re: K133508
Trade/Device Name: ResolutionMD Mobile Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: Il Product Code: LLZ Dated: February 27, 2014 Received: March 6, 2014
Dear Mr. Peterson:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
5
Page 2-Mr. Peterson
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.lda.gov/Medicall.cc/Resourcesfor You/Industrv/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.hum.
Sincerely yours,
Sm.h.7)
for
Janine M. Morris Director, Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
6
Indications for Use Statement 4
Calgary Scientific, Inc., Suite 208 - 1210 20th Ave. SE, Calgary, Applicant: Alberta, CANADA T2G 1M8
510(k) Number: K133508
Device Name: ResolutionMD™ Mobile
Indications for Use:
ResolutionMD™ Mobile is a software-based Picture Archiving and Communication System (PACS) used with general purpose computing servers and specific mobile devices. It provides for communication, storage, reformatting, rendering on the server component and communication and display of DICOM 3.0-compliant medical images as well as reports on the mobile device.
ResolutionMD Mobile provides wireless and portable access to medical images. The device is intended for use as a diagnostic, review, and analysis tool by trained professionals such as radiologists, physicians and technologists. This device is not intended to replace full workstations and should be used only when there is no access to a workstation.
ResolutionMD Mobile is not to be used for mammography.
Prescription Use _____________________________________________________________________________________________________________________________________________________________ (Part 21 CFR 801 Subpart D) OR
Over-The-Counter Use _ (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In-Vitro Diagnostics and Radiological Health (OlR)
Smh.7)
(Division Sign-Off) Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health 510(k) K133508